Voluntary nationwide recall: Akorn Operating Company LLC
May 2023Important Notices
Akorn Operating Company LLC is initiating a voluntary recall of various within-expiry human and animal products. As a result of a bankruptcy, the firm is removing several products from the market due to the discontinuation of the Quality program, which would result in the company’s inability to assure that products meet the identity, strength, quality, and purity standards. Read the full text of the Akorn voluntary recall.
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars